A randomised phase II trial comparing gemcitabine vs TS-1 in patients with resected pancreatic cancer
Phase 2
- Conditions
- Curative resection for pancreatic cancer
- Registration Number
- JPRN-UMIN000003544
- Lead Sponsor
- Dokkyo Medical University Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Not provided
Exclusion Criteria
In patietns with preoperative chemo, chemo radiation. no good oral intake less than 20 yrs old PS 2 < (ECOG) poor fanction for bone marrow, liver, kidney and lung etc.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method